Back to calendar
Intellia Therapeutics, Inc. (NTLA) Earnings
NTLA reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026
Q2 2026
Est. EPS: $-0.80
Actual EPS: $-0.81
EPS surprise: 11.06%
Company overview
Market Cap$1.5B
PriceUSD 10.77
EPS (TTM)-3.53
52-week high28.25
52-week low7.95
SectorHealth Technology
IndustryBiotechnology
Employees377